EP Lab

This channel includes news and new technology innovations for cardiac electrophysiology (EP) systems, techniques and devices using in EP labs. This includes implantable EP devices, pacemakers, implantable cardioverter defibrillators (ICD), cardiac resychronization therapy (CRT), ablation technologies, left atrial appendage (LAA) occlusion, atrial fibrilation (AF) and Holter monitors.

News | Left Atrial Appendage (LAA) Occluders

February 3, 2020 — The U.S. Food and Drug Administration (FDA) has approved a the CATALYST trial designed to assess ...

Home February 03, 2020
Home
News | Atrial Fibrillation

January 31, 2020 – The U.S. Food and Drug Administration (FDA) has given Medtronic approval to proceed with an ...

Home January 31, 2020
Home
Blog

The key question I am always asked at cardiology conferences is what are the trends and interesting new technologies I ...

Home January 24, 2020
Home
News

January 22, 2020 — The U.S. Food and Drug Administration (FDA) cleared VivaLNK's Continuous ECG Platform. It consisting ...

Home January 22, 2020
Home
News | ECG

January 22, 2020 – Bittium is exhibiting solutions for cardiology at Arab Health 2019, Jan. 27-30 in Dubai, United Arab ...

Home January 22, 2020
Home
News | Defibrillator Monitors

January 13, 2020 — Stryker announced it is launching a voluntary field action on specific units of the LifePAK 15 defibr ...

Home January 13, 2020
Home
Videos | Wearables

The Consumer Electronic Show (CES) is the world's gathering place for consumer technologies, with more than 175,000 ...

Home January 09, 2020
Home
This photo is from a MitraClip procedure during the University of Colorado visit last December.
Feature | Dave Fornell, Editor
Here are the top performing 25 videos posted to the DAIC website in the past year, based on Google Analytics. These the ...
Home December 30, 2019
Home
News | EP Lab

December 30, 2019 — Acoustoelectric cardiac imaging, a new, noninvasive cardiac imaging technology developed at the ...

Home December 30, 2019
Home
The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of the anticoagulant Eliquis (apixaban).
Feature | Antiplatelet and Anticoagulation Therapies

December 27, 2019 — The U.S. Food and Drug Administration (FDA) has approved two applications for the first generics of ...

Home December 27, 2019
Home
Peter Weiss, M.D., explains a Stereotaxis robotically navigated cardiac ablation procedure at Banner University Medicine Heart Institute.
Feature | EP Lab | J. Peter Weiss, M.D., MSc

Robotic technology, which helps carry out repetitive tasks efficiently and precisely, has been gaining ground in society ...

Home December 23, 2019
Home
Blog | Cardiovascular Business
With all eyes on rising healthcare costs, reprocessing of single-use devices has become an increasingly important ...
Home December 23, 2019
Home
News | Cardiac Diagnostics

December 19, 2019 — The U.S. Food and Drug Administration (FDA) has granted breakthrough status for a novel ECG-based ...

Home December 19, 2019
Home
The most popular content in the month of November on DAIC was by far the data from the late-breaking trials from the American Herart Association (AHA) 2019 meeting. The second item on this month's list is an overview of key heart failure takeaways from AHA by Nasrien Ibrahim, M.D., associate director of resynchronization and advanced cardiac therapeutics at Massachusetts General Hospital.  Photo by Scott Morgan/AHA.
Feature

December 16, 2019 — Here is the list of the most popular content on the Diagnostic and Interventional Cardiology (DAIC) ...

Home December 17, 2019
Home
News | ECG

December 12, 2019 — Cardiologs, a global leader in artificial intelligence (AI) cardiology diagnostics, announced today ...

Home December 12, 2019
Home
Subscribe Now